Ohrid Organics Achieves CUMCS-GAP Certification: Welcoming the Israeli Medical Cannabis Market


At Ohrid Organics, we are thrilled to share a significant milestone in our journey towards providing high-quality medical cannabis products to patients around the world. We are proud to announce that we have attained certification for the CUMCS-GAP (Control Union Medical Cannabis Standard – Good Agricultural Practice). This certification is a pivotal achievement as it grants us access to the thriving and well-established Israeli medical cannabis market, which is currently estimated to be around 50 tonnes of dry flower each year and expected to rise following recently announced reforms.

In this article, we will delve into the significance of CUMCS-GAP certification, how it positions us to serve the Israeli market’s needs and demands, and the remarkable ways in which medical cannabis can be used to treat a wide range of conditions, including PTSD, and its role as a frontline medication.

Understanding the CUMCS-GAP Certification

The CUMCS-GAP certification is a stringent quality standard that sets the benchmark for the cultivation of medical cannabis. It is designed to ensure that cannabis is grown and processed to the highest quality standards, adhering to Good Agricultural Practices (GAP) that are essential for the production of safe and effective medical cannabis products. This certification encompasses various aspects of cannabis cultivation, including seed selection, crop management, pest control, and post-harvest processes.

Achieving the CUMCS-GAP certification requires a meticulous approach to every stage of the cultivation and production process. It’s a rigorous evaluation that underscores our commitment to delivering safe, consistent, and reliable medical cannabis products to patients in Israel.

Why Israel’s Medical Cannabis Market Matters

Israel is renowned for its progressive approach to medical cannabis and research. With a well-established medical cannabis program, the country has emerged as a global leader in cannabis research and innovation. Patients in Israel benefit from access to a wide range of medical cannabis products and treatments, making the market highly competitive and regulated.

Israeli medical cannabis prescriptions cover a broad spectrum of conditions, and general practitioners (GPs) play a crucial role in prescribing cannabis to patients. This means that medical cannabis is not just a last-resort option, but it can be prescribed as a frontline medication, offering patients an alternative therapeutic approach.

The Power of Medical Cannabis in Treating PTSD

One of the remarkable applications of medical cannabis is its effectiveness in treating Post-Traumatic Stress Disorder (PTSD). In Israel, where many soldiers have been in conflict, medical cannabis is routinely used to alleviate the symptoms of PTSD. Research and clinical experience have shown that cannabis can help manage anxiety, insomnia, and nightmares often associated with this condition.

The ability of medical cannabis to provide relief for PTSD patients highlights its potential to improve the quality of life for those who have experienced traumatic events. The availability of high-quality, certified medical cannabis products through Ohrid Organics will further support patients and healthcare professionals in Israel seeking these treatment options.